Quick Takeaways
- ARK Investment Management LLC filed SCHEDULE 13G/A for Adaptive Biotechnologies Corporation Common Stock (ADPT).
- Disclosed ownership: 2.9%.
- Date of event: 31 May 2025.
ARK Investment Management LLC - 31 May 2025 SCHEDULE 13G/A Report for Adaptive Biotechnologies Corporation Common Stock (ADPT)
- Filing Manager
- ARK Investment Management LLC
- Reporting Manager
- ARK Investment Management LLC
- Symbol
- ADPT
- Shares outstanding
- 151,678,241 shares
- Disclosed Ownership
- 4,398,669 shares
- Ownership
- 2.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Jun 2025, 13:40:01 UTC
- Date of event
- 31 May 2025
- Previous filing
- 07 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARK Investment Management LLC disclosed 2.9% ownership in Adaptive Biotechnologies Corporation Common Stock (ADPT) on 31 May 2025."
What Changed
- Previous schedule filing date: 07 May 2025.
- Current filing was accepted on 06 Jun 2025, 13:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 2.9% | 4,398,669 | 4,398,669 | 0 | /s/ Kellen Carter | Kellen Carter, Chief Compliance Officer | |
| Catherine D. Wood | 2.9% | 4,398,669 | 0 | 4,398,669 | /s/ Catherine D. Wood | Catherine D. Wood, Chief Executive Officer, Chief Investment Officer |